Search results for " Vaccines"

showing 10 items of 472 documents

Precision medicine in breast cancer: reality or utopia?

2017

International audience; Many cancers, including breast cancer, have demonstrated prognosis and support advantages thanks to the discovery of targeted therapies. The advent of these new approaches marked the rise of precision medicine, which leads to improve the diagnosis, prognosis and treatment of cancer. Precision medicine takes into account the molecular and biological specificities of the patient and their tumors that will influence the treatment determined by physicians. This new era of medicine is accessible through molecular genetics platforms, the development of high-speed sequencers and means of analysis of these data. Despite the spectacular results in the treatment of cancers inc…

HER2+0301 basic medicineTumor heterogeneitymedicine.medical_specialtyPathologyMolecular subtypeslcsh:MedicineBreast NeoplasmsReviewCancer VaccinesTumor heterogeneityGeneral Biochemistry Genetics and Molecular BiologyGenetic Heterogeneity03 medical and health sciencesBreast cancer0302 clinical medicineBreast cancer[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyHumansChemotherapyMedicineMedical physicsTriple negativebusiness.industrylcsh:RPrecision medicineCancerGeneral MedicinePrecision medicinemedicine.disease3. Good health030104 developmental biology030220 oncology & carcinogenesisNeoplastic Stem CellsTriple-negativeFemaleImmunotherapyPhase III clinical trialsbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyJournal of Translational Medicine
researchProduct

Human papillomavirus-associated cancers: a survey on otorhinolaryngologists' knowledge and attitudes on prevention.

2016

Human papillomavirus (HPV) infection is a recognised causal factor associated with oropharyngeal cancers. The global burden of HPVrelated oropharyngeal cancers is on the increase and is predicted to surpass the burden of cervical cancer in the near future. As evidence is accumulating on the potential effectiveness of an HPV vaccine in controlling the oropharyngeal cancer epidemic; otorhinolaryngologists assume a key role - not only in the diagnosis and treatment of HPV-related cancers - but also in educating and advocating on HPV prevention. We conducted a survey to assess Italian otorhinolaryngologists' knowledge and attitudes regarding HPV infection, HPV-related oropharyngeal diseases and…

Health Knowledge Attitudes PracticeHuman papillomavirusPrimary preventionHead and Neck NeoplasmPapillomavirus InfectionsEuropeOtolaryngologyHuman papillomaviruKnowledgeItalyHead and Neck NeoplasmsNeoplasmsSurveys and QuestionnairesHumansFemalePapillomavirus VaccinesPapillomavirus VaccineHead and NeckActa otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale
researchProduct

Prevalence of influenza vaccination among nurses and ancillary workers in Italy: Systematic review and meta analysis

2011

Italian Ministry of Health recommends vaccination for seasonal influenza to all healthcare workers (HCW), particularly to nurses who have an important interaction with patients. The aim of this study is to conduct a systematic review in order to estimate the pooled prevalence of influenza vaccinations among nurses and ancillary workers in Italy and analyze the enhancing and hindering factors. Results: The review was performed using 15 articles, 6 containing the prevalence of vaccination for nurses and ancillary workers, while the others qualitative analysis. In all the selected articles the score calculation has been performed by using a protocol for observational studies. The nurses and an…

Health Knowledge Attitudes PracticePediatricsmedicine.medical_specialtyHealth PersonnelImmunologyMEDLINENursesInfluenza vaccination Italy helthcare workers nurses ancillary workersSettore MED/42 - Igiene Generale E ApplicataInfluenza vaccinationsinfluenza vaccination; nurses; healthcare workers; ancillary workers; italyQualitative analysisEnvironmental healthInfluenza HumanHealth careMedical StaffHumansMedicineGeneral Pharmacology Toxicology and Pharmaceuticshealthcare workersbusiness.industryVaccinationancillary workersinfluenza vaccinationHospitalsVaccinationItalyInfluenza VaccinesMeta-analysisChristian ministryObservational studybusinessHuman Vaccines
researchProduct

Factors Associated with HPV Vaccine Refusal among Young Adult Women after Ten Years of Vaccine Implementation

2018

In Italy, the Human Papillomavirus (HPV) vaccination was implemented for twelve years old girls in 2007, but its coverage was lower than the recommended level. Sicily is one of the Italian administrative regions with lower vaccination coverage, with a value of 59% for those born in 1996 increasing to 62% coverage for those born in 1999. The aim of the study was to investigate factors associated with the refusal of HPV vaccination among young adult women of Palermo, Italy. The study was approved by the Ethics Committee of the Policlinico “Paolo Giaccone” Hospital (Palermo 1) and the questionnaire was validated in a convenience sample representing 10% of the young women. A cross-s…

Health Knowledge Attitudes PracticeVaccination scheduleHealth Toxicology and Mutagenesislcsh:MedicineSettore MED/42 - Igiene Generale E Applicata0302 clinical medicineVaccination RefusalSurveys and QuestionnairesHealth belief model030212 general & internal medicineYoung adulthuman papillomavirusResponse rate (survey)education.field_of_study030219 obstetrics & reproductive medicineVaccinationHPV infectionVaccinationItalyFemalewomencatch upAdultmedicine.medical_specialtyAdolescenthuman papillomavirus; vaccine refusal; hesitancy; women; school based; Health Belief Model; gynaecologist; general practitioner; survey; catch upPopulationArticleYoung Adult03 medical and health sciencesschool basedmedicineHumanssurveyPapillomavirus Vaccineseducationbusiness.industryPublic healthPapillomavirus Infectionslcsh:RPublic Health Environmental and Occupational Healthmedicine.diseasegynaecologistCross-Sectional StudiesHuman papillomaviruFamily medicinegeneral practitionervaccine refusalhesitancybusinessCatch up; General practitioner; Gynaecologist; Health Belief Model; Hesitancy; Human papillomavirus; School based; Survey; Vaccine refusal; Women; Public Health Environmental and Occupational Health; Health Toxicology and MutagenesisHealth Belief ModelInternational Journal of Environmental Research and Public Health; Volume 15; Issue 4; Pages: 770
researchProduct

Facilitators and barriers HPV unvaccinated girls after 5 years of program implementation

2014

Understanding perceptions and characteristics of human papillomavirus (HPV) vaccinated and non-vaccinated girls can inform communication activities and vaccine delivery strategies. The purpose of this study was to evaluate knowledge and factors associated with HPV unvaccinated girls after five years of vaccination program implementation in Sicily, an Italian region with low vaccination coverage (<50.0%). A cross-sectional study was conducted through a questionnaire designed to assess knowledge and vaccination status of girls of 1997, 1998, 1999, and 2000 birth cohorts. The sample consisted of 350 girls who attended three high schools. Multivariable logistic regression analysis was conducted…

Health Knowledge Attitudes Practicemedicine.medical_specialtyAdolescentCross-sectional studyImmunologyLogistic regressionSurveys and QuestionnairesmedicineHumansImmunology and AllergyPapillomavirus VaccinesHPV vaccination barriers HPV vaccination knowledge HPV infection knowledge friends as source of information pediatrician/general practitioner as source of information HPV vaccine efficacy HPV vaccine securityStudentsSicilyPharmacologyGynecologyCervical cancerbusiness.industryPapillomavirus InfectionsVaccinationPatient Acceptance of Health Caremedicine.diseaseVaccinationCross-Sectional StudiesIncreased riskVaccination coverageFamily medicineVaccine refusalFemaleBirth cohortbusinessResearch PaperHuman Vaccines &amp; Immunotherapeutics
researchProduct

Drivers for human papillomavirus vaccination in Valencia (Spain)

2018

Objective: To describe the drivers associated with HPV vaccination in adolescent girls and their parent's opinion on the vaccine. Methods: We conducted an observational and cross-sectional study on adolescent girls and their parents in Valencia (Spain), between September 2011 and June 2012. A consultation was made at a random sample of schools of the 14-year-old girls that should have received the vaccine in the free vaccination programme. We ran a personal survey on knowledge and attitudes regarding HPV infection and the vaccine. A binary logistic regression model was performed to determine which factors were most associated with vaccination. Results: The survey was run on a binomial of 1,…

Health Knowledge Attitudes Practicemedicine.medical_specialtyHuman papillomavirusAdolescentDriversCross-sectional studyCulturePsychology AdolescentMothersLogistic regressionSampling Studies03 medical and health sciences0302 clinical medicineVaccination RefusalInfermeriamedicineHumansPapillomavirus Vaccines030212 general & internal medicineVacunacióMotivationVaccines030505 public healthImmunization Programsbusiness.industryNurselcsh:Public aspects of medicinePapillomavirus InfectionsVaccinationPublic Health Environmental and Occupational HealthHPV infectionlcsh:RA1-1270Patient Acceptance of Health Caremedicine.diseaseCountry of originConfidence intervalSurgeryVaccination RefusalVaccinationCross-Sectional StudiesSpainFamily medicineAttitudesFemaleObservational study0305 other medical sciencebusiness
researchProduct

Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants

2005

The long-term efficacy of hepatitis B vaccine, long-term effectiveness of hepatitis B immunisation programmes, immune memory induced by hepatitis B vaccine, current booster policies, and impact of hepatitis B virus mutants on immunisation programmes were reviewed at the Viral Hepatitis Prevention Board (VHPB) meeting in Sevilla, Spain, March 2004. The main focus was on universal vaccination programmes with data being presented from Italy, Saudi Arabia, Singapore, Spain, Taiwan, Thailand, The Gambia, and USA (Alaska).

Hepatitis B vaccineSettore MED/42 - Igiene Generale e ApplicataImmunization Secondarymedicine.disease_causeTimeOrthohepadnavirusparasitic diseasesHumanshepatitis B vaccination long-term efficacy virus mutantsMedicineHepatitis B VaccinesHepatitis B AntibodiesHepatitis B virusGeneral VeterinaryGeneral Immunology and MicrobiologybiologyImmunization Programsbusiness.industryPublic Health Environmental and Occupational HealthHepatitis BHepatitis Bbiology.organism_classificationmedicine.diseaseVirologyVaccinationInfectious DiseasesHepadnaviridaeDNA ViralMutationMolecular MedicineViral diseasebusinessViral hepatitisImmunologic Memorygeographic locationsVaccine
researchProduct

N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus

2011

The N-terminally myristoylated preS1 domain of the large hepatitis B surface protein (LHBs) mediates specific attachment of hepatitis B virus (HBV) to hepatocytes. Its B-cell epitopes leading to neutralization of infectivity are not yet characterized.We inserted C- and N-terminal preS1 peptides into the most immunogenic region of HBV core particles, therewith immunized Balb/c mice and determined binding properties and neutralization potential of resulting antibodies in vitro.The particles with preS1 inserts were highly immunogenic and the corresponding anti-preS antibodies strongly bound to HBV particles from chronic carriers infected with different HBV genotypes A-F. However, antibodies bi…

Hepatitis B virusHBsAgGenotypeMolecular Sequence DataIn Vitro TechniquesBiologymedicine.disease_causeMyristic AcidNeutralizationEpitopeMice03 medical and health sciencesHepatitis B Chronic0302 clinical medicinemedicineAnimalsHumansHepatitis B VaccinesAmino Acid SequenceHepatitis B AntibodiesProtein Precursors030304 developmental biologyHepatitis B virusInfectivityMice Inbred BALB C0303 health sciencesBinding SitesHepatitis B Surface AntigensSequence Homology Amino AcidHepatologyHepatitis Bmedicine.diseaseAntibodies NeutralizingVirology3. Good healthEpitope mappingbiology.proteinEpitopes B-Lymphocyte030211 gastroenterology & hepatologyAntibodyEpitope MappingJournal of Hepatology
researchProduct

Priming of cytotoxic T cell responses to exogenous hepatitis B virus core antigen is B cell dependent

2003

The hepatitis B virus (HBV) core antigen (HBcAg) has a unique ability to bind a high frequency of naive human and murine B cells. The role of HBcAg-binding naive B cells in the immunogenicity of HBcAg is not clear. The HBcAg-binding properties of naive B cells were characterized using HBcAg particles with mutated spike region (residues 76-85) sequences. Deletion of residues 76-85 (HBcDelta76-85) destroyed naive B cell binding, whereas deletion of residues 79-85 did not. HBcAg particles with an Ile instead of the natural Ala at position 80 did not bind naive B cells, whereas reversion of Ile80--Ala restored B cell binding. Destroying the B cell-binding ability of HBcAg had a marginal effect …

Hepatitis B virusMolecular Sequence DataNaive B cellPriming (immunology)Biologymedicine.disease_causeMiceAntigenVirologymedicineAnimalsCytotoxic T cellHepatitis B VaccinesAmino Acid SequenceHepatitis B AntibodiesB cellHepatitis B virusB-LymphocytesVaccines SyntheticBinding SitesImmunogenicityVirionvirus diseasesHepatitis BHepatitis B Core AntigensVirologyRecombinant Proteinsdigestive system diseasesMice Inbred C57BLHBcAgmedicine.anatomical_structureImmunizationT-Lymphocytes Cytotoxic
researchProduct

Mosaic particles formed by wild-type hepatitis B virus core protein and its deletion variants consist of both homo- and heterodimers.

2003

AbstractCo-expression in Escherichia coli of wild-type (wt) hepatitis B virus core protein (HBc) and its naturally occurring variants with deletions at amino acid positions 77–93 or 86–93 leads to formation of mosaic particles, which consist of three dimer subunit compositions. These compositions are wt/variant HBc heterodimers and two types of homodimers, formed by wt HBc or the variant HBc themselves. Mosaic particles were found also when both HBc deletion variants 77–93 and 86–93 were co-expressed in E. coli. These findings are discussed in terms of their significance for hepatitis B virus pathogenesis and prospective use of mosaic particles in vaccine development.

Hepatitis B virusvirusesProtein subunitDimerBiophysicsExpressionPlasma protein bindingBiologymedicine.disease_causeMosaic particlesBiochemistrychemistry.chemical_compoundHepatitis B virus core proteinProtein structureStructural Biologyparasitic diseasesGeneticsmedicineHepatitis B VaccinesCloning MolecularProtein Structure QuaternaryMolecular BiologyEscherichia coliSequence Deletionchemistry.chemical_classificationHepatitis B virusViral Core ProteinsWild typevirus diseasesGenetic VariationCell BiologyHepatitis BDimer formationVirologyMolecular biologydigestive system diseasesAmino acidProtein SubunitschemistryDimerizationProtein BindingFEBS letters
researchProduct